Professur für Molekulare Bildgebung und Radiochemie

Ulmenweg 18
91054 Erlangen

Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 3 Go to next page Go to last page

Toms, J., Maschauer, S., Daum, S., Reshetnikov, V., Mokhir, A., & Prante, O. (2019). Evaluation of N-alkylaminoferrocenes for in-vivo imaging of reactive oxygen species activity using PET and optical imaging. In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (pp. S32-S33). HOBOKEN: WILEY.
Potemkin, R., Strauch, B., Geisthoff, M., Kuwert, T., Prante, O., & Maschauer, S. (2019). Development of F-18-fluoroglycosylated PSMA ligands with improved kidney clearance behavior. In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (pp. S114-S115). HOBOKEN: WILEY.
Ellmann, S., Seyler, L., Evers, J., Heinen, H., Bozec, A., Prante, O.,... Bäuerle, T. (2019). Prediction of early metastatic disease in experimental breast cancer bone metastasis by combining PET/CT and MRI parameters to a Model-Averaged Neural Network. Bone, 120, 254-261.
Daum, S., Toms, J., Reshetnikov, V., Özkan, H., Hampel, F., Maschauer, S.,... Mokhir, A. (2019). Identification of Boronic Acid Derivatives as an Active Form of N-Alkylaminoferrocene-Based Anticancer Prodrugs and Their Radiolabeling with 18F. Bioconjugate Chemistry, 30(4), 1077-1086.
Schmidkonz, C., Cordes, M., Goetz, T.I., Prante, O., Kuwert, T., Ritt, P.,... Bäuerle, T. (2019). 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients. Annals of Nuclear Medicine.
Schmidkonz, C., Cordes, M., Beck, M., Goetz, T.I., Schmidt, D., Prante, O.,... Ritt, P. (2018). Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate Cancer. Clinical Nuclear Medicine, 43(8), e250-e258.
Schmidkonz, C., Hollweg, C., Beck, M., Reinfelder, J., Götz, T., Sanders, J.,... Ritt, P. (2018). 99m Tc-MIP-1404-SPECT/CT for the detection of PSMA-positive lesions in 225 patients with biochemical recurrence of prostate cancer. Prostate, 78(1), 54-63.
Amato, D., Canneva, F., Cumming, P., Maschauer, S., Groos, D., Dahlmanns, J.K.,... Müller, C.P. (2018). A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter. Molecular Psychiatry.
Maschauer, S., Einsiedel, J., Reich, D., Hübner, H., Gmeiner, P., Wester, H.J.,... Notni, J. (2017). Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors. Pharmaceuticals, 10(1), 29.
Nebel, N., Strauch, B., Maschauer, S., Lasch, R., Rampp, H., Fehler, S.,... Prante, O. (2017). [18F]Fluorophenylazocarboxylates: Design and Synthesis of Potential Radioligands for Dopamine D3 and μ‑Opioid Receptor. ACS Omega, 2, 8649-8659.
Krüll, J., Hubert, A., Nebel, N., Prante, O., & Heinrich, M. (2017). Microwave-assisted rapid one-pot synthesis of fused and non-fused indoles and 5-[18F]fluoroindoles from phenylazocarboxylates. Chemistry - A European Journal.
Nebel, N., Strauch, B., Maschauer, S., Lasch, R., Rampp, H., Fehler, S.,... Prante, O. (2017). 18F]Fluorophenylazocarboxylates: Design and Synthesis of Potential Radioligands for Dopamine D3 and μ-Opioid Receptor. ACS Omega, 2(12), 8649-8659.
Maschauer, S., & Prante, O. (2017). Radiopharmaceuticals for imaging and endoradiotherapy of neurotensin receptor-positive tumors. Journal of Labelled Compounds & Radiopharmaceuticals.
Reinfelder, J., Kuwert, T., Beck, M., Sanders, J.C., Ritt, P., Schmidkonz, C.,... Goebell, P. (2017). First Experience With SPECT/CT Using a 99mTc-Labeled Inhibitor for Prostate-Specific Membrane Antigen in Patients With Biochemical Recurrence of Prostate Cancer. Clinical Nuclear Medicine, 42(1), 26-33.
Keller, M., Maschauer, S., Brennauer, A., Tripal, P., Koglin, N., Dittrich, R.,... Prante, O. (2017). Prototypic (18)F-Labeled Argininamide-Type Neuropeptide Y Y1R Antagonists as Tracers for PET Imaging of Mammary Carcinoma. Acs Medicinal Chemistry Letters, 8(3), 304-309.
Maschauer, S., Heilmann, M., Waengler, C., Schirrmacher, R., & Prante, O. (2016). Radiosynthesis and Preclinical Evaluation of (18)F-Fluoroglycosylated Octreotate for Somatostatin Receptor Imaging. Bioconjugate Chemistry, 27(11), 2707-2714.
Maschauer, S., Gahr, S., Gandesiri, M., Tripal, P., Schneider-Stock, R., Kuwert, T.,... Prante, O. (2016). In vivo monitoring of the anti-angiogenic therapeutic effect of the pan-deacetylase inhibitor panobinostat by small animal PET in a mouse model of gastrointestinal cancers. Nuclear Medicine and Biology, 43(1), 27-34.
Maschauer, S., Einsiedel, J., Hübner, H., Gmeiner, P., & Prante, O. (2016). 18F- and 68Ga-Labeled Neurotensin Peptides for PET Imaging of Neurotensin Receptor 1. Journal of Medicinal Chemistry, 59, 6480-6492.
Nebel, N., Maschauer, S., Kuwert, T., Hocke, C., & Prante, O. (2016). In Vitro and In Vivo Characterization of Selected Fluorine-18 Labeled Radioligands for PET Imaging of the Dopamine D3 Receptor. Molecules, 21(9).
Nebel, N., Maschauer, S., Hocke, C., Hübner, H., Gmeiner, P., & Prante, O. (2016). Optimization and synthesis of an 18F-labeled dopamine D3 receptor ligand using [18F]fluorophenylazocarboxylic tert-butylester. Journal of Labelled Compounds and Radiopharmaceuticals, 59(2), 48-53.

Zuletzt aktualisiert 2019-24-04 um 10:20